Konferansedeltagelse:

EANM 2018
EANM 2017
EANM 2016

"Dosimetric methods in a new radioimmunotherapy" Â— MedFys 2015, Kvitfjell
Posterpresentasjon

"Pre-Dosing with Cold Antibody (HH1) Reduces Red Bone Marrow Absorbed Doses in Patients Treated with the Novel Antibody-Radionuclide-Conjugate 177-Lu-DOTA-HH1" - EANM 2016, Barcelona, Poster (Highlighted)

"Pre-dosing with lilotomab prior to antibody-radionuclide conjugate therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumour to red marrow absorbed dose in non-Hodgkin lymphoma patients" - EANM 2017, Wien, Poster (Highlighted, Nominert til Marie Curie-prisen)


